Data from: Health Canada’s use of accelerated review pathways and therapeutic innovation, 1995-2016: a cohort study

Lexchin J

Date Published: July 12, 2018

DOI: https://doi.org/10.5061/dryad.0bf6000

Files in this package

Content in the Dryad Digital Repository is offered "as is." By downloading files, you agree to the Dryad Terms of Service. To the extent possible under law, the authors have waived all copyright and related or neighboring rights to this data. CC0 (opens a new window) Open Data (opens a new window)

Title Supplementary Table 2
Downloaded 1 time
Description All drugs approved between 1995-2016 that did not receive therapeutic assessments
Download Supplementary Table 2.csv (8.433 Kb)
Details View File Details
Title Supplementary Table 1
Downloaded 1 time
Description All drugs approved between 1995-2016 that received therapeutic assessments from Patented Medicine Prices Review Board and/or La revue Prescrire
Download Supplementary Table 1.csv (36.40 Kb)
Details View File Details

When using this data, please cite the original publication:

Citation is not yet available for this publication from BMJ Open. It will become available shortly after the publication appears.

Additionally, please cite the Dryad data package:

Lexchin J (2018) Data from: Health Canada’s use of accelerated review pathways and therapeutic innovation, 1995-2016: a cohort study. Dryad Digital Repository. https://doi.org/10.5061/dryad.0bf6000
Cite | Share
Download the data package citation in the following formats:
   RIS (compatible with EndNote, Reference Manager, ProCite, RefWorks)
   BibTex (compatible with BibDesk, LaTeX)

Search for data

Be part of Dryad

We encourage organizations to: